No trading implications - this is routine insider activity related to pre-existing compensation plans. Monitor for any subsequent open market transactions which would indicate active buying or selling sentiment.
Price Chart
Executive Summary
Genmab disclosed routine insider transactions involving the vesting of restricted stock units for six executive officers, including CEO Jan van de Winkel and CFO Anthony Pagano. The transactions are standard compensation events with no material financial impact.
Key Facts
- CEO Jan van de Winkel acquired 8,525 shares through RSU vesting at DKK 1,758.50 per share
- CFO Anthony Pagano acquired 4,206 shares through RSU vesting at DKK 1,758.50 per share
- Four other executive officers acquired between 439 and 5,186 shares through RSU vesting
- All transactions occurred on April 1, 2026, and were net settled outside the market
- Disclosure made pursuant to EU Market Abuse Regulation Article 19
Financial Impact
Approximately DKK 33.3 million ($4.8 million) in total share value acquired through RSU vesting
Risk Factors
- None - this is a standard regulatory disclosure of pre-arranged compensation events
- Potential misinterpretation by investors as active insider buying when it is actually automatic RSU vesting
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000057 |
| Document: gmab_20260401xx6kx2.htm | 0001434265-26-000057 |
| Document: 0001434265-26-000057-index-headers.html | 0001434265-26-000057 |
| Document: 0001434265-26-000057-index.html | 0001434265-26-000057 |
| Document: 0001434265-26-000057.txt | 0001434265-26-000057 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 29, 2026 21w ago | 6-K | $251.55 $262.00 | ▲ +4.15% | ▲ +5.45% | $439.05 (+74.54%) |
May 13, 2026 23w ago | 6-K | $268.24 $249.00 | ▼ −7.17% | ▼ −6.56% | $439.05 (+63.68%) |
May 12, 2026 24w ago | 6-K | $264.64 $249.00 | ▼ −5.91% | ▼ −4.18% | $439.05 (+65.90%) |
May 8, 2026 24w ago | 6-K | $259.60 $249.00 | ▼ −4.08% | ▼ −3.78% | $439.05 (+69.13%) |
Apr 17, 2026 27w ago | 6-K | $281.75 $265.27 | ▼ −5.85% | ▼ −11.22% | $439.05 (+55.83%) |
Apr 17, 2026 27w ago | 6-K | $281.75 $265.27 | ▼ −5.85% | ▼ −11.22% | $439.05 (+55.83%) |
Apr 14, 2026 28w ago | 6-K | $273.25 $259.60 | ▼ −5.00% | ▼ −11.29% | $439.05 (+60.68%) |
Apr 1, 2026 29w ago | 6-K | $265.00 $255.25 | ▼ −3.68% | ▼ −13.40% | $439.05 (+65.68%) |
Apr 1, 2026 29w ago | 6-K | $265.00 $255.25 | ▼ −3.68% | ▼ −13.40% | $439.05 (+65.68%) |
Mar 30, 2026 30w ago | 6-K | $265.00 $255.25 | ▼ −3.68% | ▼ −13.10% | $439.05 (+65.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers